Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth

Oncogene. 2016 Mar 3;35(9):1206. doi: 10.1038/onc.2015.418.
No abstract available

Publication types

  • Published Erratum